Amid rising obesity rates, unsupervised weight loss injections are leading many young Indians to the hospital. One case involved a 32-year-old from Agra who developed gastroparesis after self-administering tirzepatide, a powerful weight loss drug, purchased without medical oversight. This troubling pattern is increasingly evident among those aged 25 to 40, who are sourcing weight loss medications from the grey market due to their unavailability in India.
The obsession with weight loss surged following the popularity of Ozempic, a diabetes drug known for its appetite-suppressing qualities. Celebrities and influencers propelled the demand even higher when other drugs like Eli Lilly’s Zepbound gained FDA approval. As these hormonal treatments mimic the body’s insulin production, experts warn of dangerous side effects if used without proper medical advice.
Overdosing on these medications poses serious health risks, causing a cascade of gastrointestinal issues such as gastroparesis. Anecdotal evidence from healthcare providers reveals young individuals are modifying their dosages without consulting doctors, leading to repeated hospital admissions. Despite understanding the potential dangers, many users return to these medications, driven by the desire to maintain rapid weight loss.
Doctors also highlighted increasing cases across major cities in India, signaling a nationwide concern. Patients often experience mild appetite loss as a side effect, but many do not cease usage, leading to dangerous complications. Physicians stress that these drugs require complementary lifestyle changes and should not be viewed as solitary solutions.
Beyond the primary effects, misuse of weight loss drugs can result in unwanted physical changes and mental health issues. Reports of decreased muscle mass and even suicidal thoughts during treatment are becoming alarmingly frequent. Until these medications are regulated and available legally in India, the potential risks far outweigh the benefits, prompting calls for medical consultation before initiation.
Young Indians are increasingly using unregulated weight loss drugs like tirzepatide and semaglutide independently, leading to severe health complications like gastroparesis. The trend has escalated following the popularity of medications initially intended for diabetes management. Unsupervised use often results in overdoses, exacerbating health issues and increasing hospital visits, especially among individuals aged 25 to 40.
The surge in unsupervised weight loss drug use among young Indians highlights a severe public health issue. While such medications promise quick results, they come with dangerous risks, including serious gastrointestinal complications like gastroparesis. Doctors emphasize the importance of oversight and proper dosage, warning that self-treatment could lead to long-lasting health consequences. Education on how these medications work is crucial in mitigating their misuse, especially as the trend continues to grow.
Original Source: indianexpress.com
